2018-10-05 Comments Off on FDA Approves Genentech’s Xolair (omalizumab) Prefilled Syringe Formulation FDA Approves Genentech’s Xolair (omalizumab) Prefilled Syringe Formulation South San Francisco, CA — September 28, 2018 — Genentech,